[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![nimeshscnbc Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::4687762273.png) Nimesh Shah [@nimeshscnbc](/creator/twitter/nimeshscnbc) on x 68.5K followers
Created: 2025-06-26 02:28:39 UTC

CITI on DR Reddys
Sell, TP cut to Rs XXX from Rs 1040
Expect decline in gRevlimid sales & related PLI incentives to result in drag of $750-780m in EBITDA, which would be difficult to offset
Supply of remaining quantity of gRevlimid may help next X qtrs, though is already built in


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1938061818792226912/c:line.svg)

**Related Topics**
[$750780m](/topic/$750780m)
[pli](/topic/pli)
[dr reddys](/topic/dr-reddys)

[Post Link](https://x.com/nimeshscnbc/status/1938061818792226912)